Deletion and translocation involving chromosome 3(p14) in two tumorigenic Kaposi's sarcoma cell lines

Journal of the National Cancer Institute

Volumn 88, Issue 7, 1996, Pages 450-455

  Popescu, Nicholas C ^a,d   Zimonjic, Drazen B ^a   Leventon Kriss, Sophie ^b   Bryant, Joseph L ^c   Lunardi Iskandar, Yanto ^a,e   Gallo, Robert C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; CANCER GENETICS; CHROMOSOME 3P; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME G BAND; CHROMOSOME TRANSLOCATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KAPOSI SARCOMA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CELL LINE; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; KIDNEY NEOPLASMS; MICE; SARCOMA, KAPOSI; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029942509     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.7.450     Document Type: Article

References (36)

1. Bishop JM. The molecular genetics of cancer. Science 1987;235:305-11.
2. Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci U S A 1993;90:10914-21.
3. Huebner K, Nowell PC, Croce CM. Lineage-specific gene rearrangement/deletion: a non-conservative model. Cancer Res 1989;49: 4071-4.
4. Sandberg AA. The chromosomes in human cancer and leukemia. 2nd ed. New York: Elsevier Science, 1990.
5. Solomon E, Borrow J, Goddard AD. Chromosome aberrations and cancer. Science 1991; 254:1153-60.
6. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994;372:143-9.
7. CDC Task Force on KS and opportunistic infections. N Engl J Med 1982;306:248-52.
8. Safai B, Johnson KG, Myskowski PL, Koziner B, Yang SY, Cunningham-Rundles S, et al. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:744-50.
9. Groopman JE. Biology and therapy of epidemic Kaposi's sarcoma. Cancer 1987;59:633-7.
10. Ruszczak Z, Mayer-Da Silva A, Orfanos CE. Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions. Am J Dermatopathol 1987;9:388-98.
11. + T cells. Science 1988;242:426-30.
12. Oettle AG. Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta Un Int Contra Cancer 1962;18:330-63.
13. Scappaticci S, Cerimele D, Cottoni F, Pasquali F, Fraccaro M. Chromosomal aberrations in lymphocyte and fibroblast cultures of patients with the sporadic type of Kaposi sarcoma. Hum Genet 1986;72:311-7.
14. Saikevych IA, Mayer M, White RL, Ho RC. Cytogenetic study of Kaposi's sarcoma associated with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1988;112:825-8.
15. Lunardi-Iskandar Y, Bryant JL, Zeman RA, Lam VH, Samaniego F, Besnier JM, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone [published erratum appears in Nature 1995; 376:447] [see comment citations in Medline]. Nature 1995;375:64-8.
16. Lunardi-Iskandar Y, Gill P, Lam VH, Zeman RA, Michaels F, Mann DL. et al. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma [see comment citation in Medline]. J Natl Cancer Inst 1995;87:974-81.
17. Siegal B, Leventon-Kriss S, Schiffer A, Sayar J, Engelberg I, Vonsover A, et al. Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection. Cancer 1990;65:492-8.
18. Zimonjic DB, Popescu NC. An improved procedure for chromosome preparations from solid tumors [letter]. Cancer Genet Cytogenet 1994;72:161.
19. Chen LC, Matsamura K, Deng G, Kurisu W, Ljung BM, Lerman MI, et al. Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Res 1994;54:3021-4.
20. LaForgia S, Lasota J, Latif F, Boghosian-Sell L, Kastury K, Ohta M, et al. Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation t(3;8)-(p14.2;q24.1). Cancer Res 1993;53:3118-24.
21. Zimonjic DB, Popescu NC, Matsui T, Ito M, Chihara K. Localization of the human cholecystokinin-B/gastrin receptor gene (CCKBR) to chromosome 11p15.5→p15.4 by fluorescence in situ hybridization. Cytogenet Cell Genet 1994;65:184-5.
22. Popescu N, Zimonjic D, Hatch C, Bonner W. Chromosomal mapping of the human histone gene H2AZ to 4q24 by fluorescence in situ hybridization. Genomics 1994;20:333-5.
23. Xu J, Wang N. Identification of chromosomal structural alterations in human ovarian carcinoma cells using combined GTG-banding and repetitive fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 1994;74:1-7.
24. Mitelman F, editor. ISCN: guidelines for cancer cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Basel: Karger, 1991.
25. Yunis JJ, Soreng AL. Constitutive fragile sites and cancer. Science 1984;226:1199-204.
26. Smeets DF, Scheres JM, Hustinx TW. The most common fragile site in man is 3p14. Hum Genet 1986;72:215-20.
27. Popescu NC. Chromosome fragility and instability in human cancer. Crit Rev Oncog 1994;5:121-40.
28. Paradee W, Mullins C, He Z, Glover T, Wilke C, Opalka B, et al. Precise localization of aphidicolin-induced breakpoints on the short arm of human chromosome 3. Genomics 1995;27:358-61.
29. Markkanen A, Ruutu T, Rasi V, Franssila K, Knuutila S, de la Chapelle A. Constitutional translocation t(3;6)(p14;p11) in a family with hematologic malignancies. Cancer Genet Cytogenet 1987;25:87-95.
30. Naylor SL, Johnson BE, Minna JD, Sakaguchi AY. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 1987; 329:4514.
31. Yokota J, Tsukada Y, Nakajima T, Gotoh M, Shimosata Y, Mori N, et al. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix, Cancer Res 1989;49:3598-601.
32. Zbar B, Brauch H, Talmadge C, Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 1987;327:721-4.
33. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 1994;54: 4481-7.
34. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene [see comment citation in Medline]. Science 1993; 260:1317-20.
35. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1992;61:759-67.
36. Rabkin CS, Bedi G, Musaba E, Sunkutu R, Mwansa N. AIDS-related Kaposi's sarcoma, a clonal neoplasm. Clin Cancer Res 1995;1:256-60.